Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHARON BIO-MEDICINE vs BACIL PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHARON BIO-MEDICINE BACIL PHARMA SHARON BIO-MEDICINE/
BACIL PHARMA
 
P/E (TTM) x 0.1 66.3 0.1% View Chart
P/BV x - 21.1 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 SHARON BIO-MEDICINE   BACIL PHARMA
EQUITY SHARE DATA
    SHARON BIO-MEDICINE
Mar-23
BACIL PHARMA
Mar-24
SHARON BIO-MEDICINE/
BACIL PHARMA
5-Yr Chart
Click to enlarge
High RsNA15 0.0%   
Low RsNA5 0.0%   
Sales per share (Unadj.) Rs338.50-  
Earnings per share (Unadj.) Rs33.0-0.1 -32,938.9%  
Cash flow per share (Unadj.) Rs51.6-0.1 -53,365.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00- 
Book value per share (Unadj.) Rs-1,024.92.1 -49,766.5%  
Shares outstanding (eoy) m5.765.89 97.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x00-  
Avg P/E ratio x0-96.4 -0.0%  
P/CF ratio (eoy) x0-99.8 -0.0%  
Price / Book Value ratio x04.7 -0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m057 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m3331 33,629.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,9500-  
Other income Rs m451 3,401.5%   
Total revenues Rs m1,9941 152,241.2%   
Gross profit Rs m254-2 -13,557.8%  
Depreciation Rs m1070 537,100.0%   
Interest Rs m10 6,200.0%   
Profit before tax Rs m190-1 -32,211.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m00-   
Profit after tax Rs m190-1 -32,211.9%  
Gross profit margin %13.00- 
Effective tax rate %0-0.2 -0.0%   
Net profit margin %9.70- 
BALANCE SHEET DATA
Current assets Rs m1,7581 338,105.8%   
Current liabilities Rs m3,3911 300,067.3%   
Net working cap to sales %-83.70- 
Current ratio x0.50.5 112.7%  
Inventory Days Days170- 
Debtors Days Days4880- 
Net fixed assets Rs m1,37212 11,266.5%   
Share capital Rs m1265 17.6%   
"Free" reserves Rs m-5,915-53 11,130.9%   
Net worth Rs m-5,90312 -48,668.1%   
Long term debt Rs m5,5800-   
Total assets Rs m3,13013 24,648.9%  
Interest coverage x307.5-58.0 -530.2%   
Debt to equity ratio x-0.90-  
Sales to assets ratio x0.60-   
Return on assets %6.1-4.6 -132.7%  
Return on equity %-3.2-4.9 66.2%  
Return on capital %-59.0-4.8 1,229.3%  
Exports to sales %73.20-  
Imports to sales %7.50-  
Exports (fob) Rs m1,428NA-   
Imports (cif) Rs m145NA-   
Fx inflow Rs m1,4280-   
Fx outflow Rs m1660-   
Net fx Rs m1,2630-   
CASH FLOW
From Operations Rs m4110 -1,370,466.7%  
From Investments Rs m-281 -3,555.1%  
From Financial Activity Rs mNA-1 -36.5%  
Net Cashflow Rs m3840 295,107.7%  

Share Holding

Indian Promoters % 0.0 20.7 -  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 100.0 79.3 126.1%  
Shareholders   24,837 6,902 359.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHARON BIO-MEDICINE With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SHARON BIO-MEDICINE vs BACIL PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SHARON BIO-MEDICINE vs BACIL PHARMA Share Price Performance

Period SHARON BIO-MEDICINE BACIL PHARMA S&P BSE HEALTHCARE
1-Day -1.53% -1.99% 1.23%
1-Month -8.29% 12.19% -0.24%
1-Year -41.85% 636.27% 43.62%
3-Year CAGR -33.57% 100.62% 20.35%
5-Year CAGR -40.63% 85.09% 26.24%

* Compound Annual Growth Rate

Here are more details on the SHARON BIO-MEDICINE share price and the BACIL PHARMA share price.

Moving on to shareholding structures...

The promoters of SHARON BIO-MEDICINE hold a 0.0% stake in the company. In case of BACIL PHARMA the stake stands at 20.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SHARON BIO-MEDICINE and the shareholding pattern of BACIL PHARMA.

Finally, a word on dividends...

In the most recent financial year, SHARON BIO-MEDICINE paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

BACIL PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of SHARON BIO-MEDICINE, and the dividend history of BACIL PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.